ATE115860T1 - Stabile immunogene zusammensetzung. - Google Patents

Stabile immunogene zusammensetzung.

Info

Publication number
ATE115860T1
ATE115860T1 AT90610064T AT90610064T ATE115860T1 AT E115860 T1 ATE115860 T1 AT E115860T1 AT 90610064 T AT90610064 T AT 90610064T AT 90610064 T AT90610064 T AT 90610064T AT E115860 T1 ATE115860 T1 AT E115860T1
Authority
AT
Austria
Prior art keywords
immunogenic composition
stable immunogenic
stable
immunogen
bloom
Prior art date
Application number
AT90610064T
Other languages
English (en)
Inventor
Kuniaki Nerome
Kuniharu Seki
Katsuhiko Ohyama
Original Assignee
Nisshin Oil Mills Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nisshin Oil Mills Ltd filed Critical Nisshin Oil Mills Ltd
Application granted granted Critical
Publication of ATE115860T1 publication Critical patent/ATE115860T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1658—Proteins, e.g. albumin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
AT90610064T 1989-09-29 1990-09-28 Stabile immunogene zusammensetzung. ATE115860T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP25647289 1989-09-29

Publications (1)

Publication Number Publication Date
ATE115860T1 true ATE115860T1 (de) 1995-01-15

Family

ID=17293111

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90610064T ATE115860T1 (de) 1989-09-29 1990-09-28 Stabile immunogene zusammensetzung.

Country Status (10)

Country Link
US (1) US5176909A (de)
EP (1) EP0420785B1 (de)
JP (1) JPH03173829A (de)
CN (1) CN1032348C (de)
AT (1) ATE115860T1 (de)
AU (1) AU634823B2 (de)
CA (1) CA2026508A1 (de)
DE (1) DE69015305T2 (de)
RU (2) RU1836081C (de)
ZA (1) ZA907737B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5334394A (en) * 1990-06-22 1994-08-02 The Regents Of The University Of California Human immunodeficiency virus decoy
US5178882A (en) * 1990-06-22 1993-01-12 The Regents Of The University Of California Viral decoy vaccine
CA2083553A1 (en) * 1991-11-25 1993-05-26 Kuniharu Seki Immunogen composition
WO1997013531A1 (en) * 1995-10-13 1997-04-17 Zynaxis, Inc. Solid, orally administrable viral vaccines and methods of preparation
AU3866397A (en) * 1996-08-20 1998-03-06 Freund Industrial Co. Ltd. Microspheres containing immunogens, process for producing the same, and method for immunizing animals with the use of the same
US5741680A (en) * 1996-09-03 1998-04-21 Cera Products, Inc. Buffer composition base and method of formulation for oral vaccine delivery
AUPQ761200A0 (en) * 2000-05-19 2000-06-15 Hunter Immunology Limited Compositions and methods for treatment of mucosal infections
US20040057969A1 (en) * 2002-09-20 2004-03-25 Smith Mark L Compositions containing stabilized hepatitis antigen and methods of their use
DE60311526T2 (de) * 2002-11-01 2007-10-31 Glaxosmithkline Biologicals S.A. Immunogene zusammensetzung
CA2527721C (en) * 2003-06-10 2016-05-10 University Of Saskatchewan Chimeric adenovirus capsid proteins
JP2007060963A (ja) * 2005-08-30 2007-03-15 Eiyo Byorigaku Kenkyusho:Kk 動物に病原体感染症を発症させるための動物用カプセル製剤およびそれを用いて動物に病原体感染症を発症させる方法
RU2010123692A (ru) * 2007-11-13 2011-12-20 Геркулес Инкорпорейтед (Us) Диспергируемая в воде композиция энтеросолюбильного покрытия для нутрицевтических и фармацевтических лекарственных форм
RU2497541C1 (ru) * 2012-07-20 2013-11-10 федеральное государственное бюджетное учреждение "Научно-исследовательский институт эпидемиологии и микробиологии имени почётного академика Н.Ф. Гамалеи" Министерства здравоохранения Российской Федерации Фармацевтическая композиция на основе лигандов паттерн-распознающих рецепторов, способ ее использования в качестве иммуностимулятора для лечения инфекций, вызванных бактериальными и вирусными патогенами, способ ее использования в качестве адъюванта в составе вакцин
JP2016164149A (ja) * 2015-02-27 2016-09-08 尾木 大 コーティング剤組成物
CN114478074B (zh) * 2022-01-12 2023-04-28 中北大学 羟基磷灰石嫁接钴包覆陶瓷复合粉末及其制备和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE621398A (de) * 1900-01-01
FR1497584A (fr) * 1966-08-11 1967-10-13 Roussel Uclaf Procédé de fabrication de microcapsules
JPS5537971A (en) * 1978-09-11 1980-03-17 Agency Of Ind Science & Technol Fuel-injection-timing detector of diesel engine
FR2464093A1 (fr) * 1979-08-30 1981-03-06 Roussel Uclaf Procede de preparation de suspensions ou de poudres stables de microcapsules stables et d'une porosite variable et les produits ainsi obtenus
SE441009B (sv) * 1982-03-08 1985-09-02 Kjell Nilsson Sett att immobilisera levande biomaterial i perlformiga polymerer
GB8326633D0 (en) * 1983-08-04 1983-11-09 Unilever Plc Compositions
EP0142192A1 (de) * 1983-10-22 1985-05-22 Akzo N.V. Herstellung von Immunogenen bestehend aus an Glykosid enthaltenden Trägern gebundenen antigenen Determinanten
US4873090A (en) * 1985-03-27 1989-10-10 Broncostat Pty. Limited Non-adjuvenated vaccine
JPH062665B2 (ja) * 1987-10-06 1994-01-12 新田ゼラチン株式会社 ゼラチン組成物

Also Published As

Publication number Publication date
DE69015305D1 (de) 1995-02-02
CN1032348C (zh) 1996-07-24
EP0420785B1 (de) 1994-12-21
RU2069567C1 (ru) 1996-11-27
RU1836081C (ru) 1993-08-23
JPH03173829A (ja) 1991-07-29
ZA907737B (en) 1991-07-31
EP0420785A2 (de) 1991-04-03
AU6360790A (en) 1991-04-11
CA2026508A1 (en) 1991-03-30
US5176909A (en) 1993-01-05
CN1050987A (zh) 1991-05-01
AU634823B2 (en) 1993-03-04
EP0420785A3 (en) 1991-07-31
DE69015305T2 (de) 1995-05-18

Similar Documents

Publication Publication Date Title
ATE115860T1 (de) Stabile immunogene zusammensetzung.
ATE108650T1 (de) Methode und zusammensetzung zur oralen verabreichung von bioaktiven mitteln zur peyer's flecken.
PT839525E (pt) Preparacao de libertacao prolongada
DK0395431T3 (da) Subcoatet simuleret kapsellignende medikament
BRPI9509286B8 (pt) microcápsulas medicamentosas e/ou nutricionais para administração per si.
DE3881281D1 (de) Stabilisierter attenuierter lebender impfstoff und seine herstellung.
DE3766200D1 (de) L-dopa enthaltendes arzneimittel.
KR910009241A (ko) 치근막 질환 치료용 서방성 조성물
FR2700957B1 (fr) Composition de vaccin sous-unitaire recombinant vivant et procédé de préparation.
NO892512D0 (no) Oralt preparat av buspiron og salter derav.
IL85144A0 (en) Controlled and delayed release oral pharmaceutical compositions and their preparation
DE69009211D1 (de) Derivate von Thiazolidin-4-carbonsäure, deren Herstellung und sie enthaltende pharmazeutische Zusammensetzungen.
NO911798L (no) 3'-deamino-4'-deoksy-4'-amino-8-fluorantracykliner og deres fremstilling.
IT8722791A0 (it) Attenuato cosi' ottenuto. procedimento per la preparazione di un ceppo mutante migliorato di bordetella bronchiseptica utile per un vaccino attenuato vivo per la protezione da infezioni di b.bronchiseptica e vaccino ar vivo
IL81197A0 (en) Methionine-substituted 1,4-dihydropyridines,their preparation and medicaments containing them
ZA862478B (de)
ATE103279T1 (de) 2,3-thiomorpholinedion-2-oxim-derivate, arzneimittelzusammensetzungen und verfahren zur herstellung.
IT9009379A0 (it) Procedimento per la preparazione di protesi dentali fisse, e protesi cosi' realizzate
FR2646850B1 (fr) Derives d'acide dibenzo(b,e)thiepinne-3-acetique, leur preparation et leur application en therapeutique

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee